I had a few thoughts swirling around somewhere in what's left of my brain when I was posting various bits of info.
I will try to articulate those.
* I have been struck by the imbalance in how CCSVI is portrayed and described vs. chemo, stem cell transplantation, tovaxin, tysabri, etc. It would be fascinating to see a direct comparison using the same standards -- for instance, warning people using infusion therapies or steroids about every detail of every danger of those, including the danger of infection if they need a portacath, which many people do when they get a monthly infusion. Portacaths are far more likely to have complications and infections than the site of a percutaneous venoplasty.
For instance, I used monthly IVIg, which had serious side effects from each infusion, yet everyone encouraged me and even suggested using steroids -- which carry their own serious side effects -- to deal with the side effects of the infusion reactions. If I saw a chart comparing this to one venogram -- ? And yet every so often the MS newsletter would publish an update on IVIg research, without sending everyone a blurb on the dangers of infusion reactions.
Do you get my point> When we received a newsletter update on CCSVI, the newsletter also pointedly sent info on the dangers of venogram complications -- which we are told by medical experts are actually negligible. If the newsleter were consistent, this would be like sending the package insert every time we get an update on Fingolimod, or Campath, for instance. Clearly they don't do this. Ergo, the imbalance we have seen. THAT is what I am objecting to.
* Second thing -- about the marketing. I also believe that professional marketers are better than amateurs.

But it felt uncomfortable to see that they were specifically targeting MS societies with specific goals to "probe" for information about people with MS. It also states that as part of their job performance they will be evaluated on signing up specific numbers of new clients.
Well, these are sales people, not doctors, and it feels like a slippery area to bring them in and have them become part of the financial structure of the MS Society, make it part of their job description to gain trust and "influence" their thoughts and decisions, and sign up as many new people as possible for their drug.
This has nothing to do with CCSVI; it just feels tangled to me. I don't like to feel like someone's job performance depends on treating my illness with a potentially fatal drug. Let's just say there's a chance they may not be completely objective.
Of course I know this is reality. I am just musing out loud about it.
* Third thing -- I am amazed by the extensive structure of the MS Society in the US. I read the bio of Sylvia Lawry. Her commitment to a cure and her accomplishments are incredible. I would suggest that anyone here read those. She started the whole society to find a cure, to be dedicated to research. Then they branched into support as well.
I read the recent annual reports (2004-2008 are available online). Money for research averages 21 percent. Support for people with MS averages about the same. Public and professional education averages 18 percent. They have some high salaries in there, but admin costs stay about 6-7 percent. Overall, really not bad.
I tried to find out how many of their staff have MS but I was not successful. Obviously lots of their volunteers do, but I was curious about actual employees (full or part-time).
More to say but I'm tired.
